Kintor Pharmaceutical Limited (KNTPF)
OTCMKTS · Delayed Price · Currency is USD
0.3643
+0.0349 (10.60%)
At close: Aug 18, 2025
Kintor Pharmaceutical Market Cap
Kintor Pharmaceutical has a market cap or net worth of $138.55 million as of August 22, 2025. Its market cap has increased by 141.50% in one year.
Market Cap
138.55M
Enterprise Value
136.42M
Revenue
685.02K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.36
Market Cap Chart
Since May 22, 2020, Kintor Pharmaceutical's market cap has decreased from 1.02B to 138.55M, a decrease of -86.47%. That is a compound annual growth rate of -31.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 138.55M | 156.26% |
| Dec 31, 2024 | 54.07M | -42.09% |
| Dec 29, 2023 | 93.37M | -83.48% |
| Dec 30, 2022 | 565.31M | -7.54% |
| Dec 31, 2021 | 611.38M | 22.68% |
| Dec 31, 2020 | 498.34M | -51.33% |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 632.06M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.33M |
| Northwest Biotherapeutics | 366.64M |